Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.55−0.21 (-7.61%)
Close on Nov 18, 2026Market cap $104.71MP/E –Yield –
Scienture revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Scienture's revenue for the twelve months ending Sep 30, 2025 was $653.39K. For fiscal 2025 it was $431.61K, up 215.9% from the year before. Over ten years it grew -17.4% a year on average. The highest annual figure on record is $17.12M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $431.61K | +215.9% |
| FY2024 | Dec 31, 2024 | $136.64K | -90.0% |
| FY2023 | Dec 31, 2023 | $1.36M | -86.7% |
| FY2022 | Dec 31, 2022 | $10.25M | +3.6% |
| FY2021 | Dec 31, 2021 | $9.89M | -42.2% |
| FY2020 | Dec 31, 2020 | $17.12M | +130.3% |
| FY2019 | Dec 31, 2019 | $7.44M | +94.1% |
| FY2018 | Dec 31, 2018 | $3.83M | +30.7% |
| FY2017 | Dec 31, 2017 | $2.93M | +18.1% |
| FY2016 | Dec 31, 2016 | $2.48M | -14.8% |
| FY2015 | Dec 31, 2015 | $2.91M | +94.7% |
| FY2014 | Dec 31, 2014 | $1.50M | +56.5% |
| FY2013 | Dec 31, 2013 | $955.88K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $343.64K | +3250.0% |
| Q1 FY2026 | Mar 31, 2026 | $56.33K | +6.1% |
| Q3 FY2025 | Sep 30, 2025 | $590.05K | +809.7% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $10.26K | -92.0% |
| Q4 FY2024 | Dec 31, 2024 | $53.08K | -86.5% |
| Q3 FY2024 | Sep 30, 2024 | $64.86K | -82.3% |
| Q2 FY2024 | Jun 30, 2024 | $18.70K | -96.2% |
| Q4 FY2023 | Dec 31, 2023 | $128.66K | -94.3% |
| Q3 FY2023 | Sep 30, 2023 | $392.29K | -80.9% |
| Q2 FY2023 | Jun 30, 2023 | $366.53K | -88.8% |
| Q1 FY2023 | Mar 31, 2023 | $493.32K | -84.8% |
| Q4 FY2022 | Dec 31, 2022 | $2.26M | -5.5% |
| Q3 FY2022 | Sep 30, 2022 | $2.06M | -19.4% |
| Q2 FY2022 | Jun 30, 2022 | $3.28M | +72.7% |
| Q1 FY2022 | Mar 31, 2022 | $3.24M | +6.1% |
| Q4 FY2021 | Dec 31, 2021 | $2.39M | +19.7% |
| Q3 FY2021 | Sep 30, 2021 | $2.55M | -59.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.90M | -71.2% |
| Q1 FY2021 | Mar 31, 2021 | $3.05M | +38.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.99M | +17.6% |
| Q3 FY2020 | Sep 30, 2020 | $6.33M | +174.0% |
| Q2 FY2020 | Jun 30, 2020 | $6.59M | +244.0% |
| Q1 FY2020 | Mar 31, 2020 | $2.20M | +45.7% |
| Q4 FY2019 | Dec 31, 2019 | $1.70M | +31.1% |
| Q3 FY2019 | Sep 30, 2019 | $2.31M | +172.7% |
| Q2 FY2019 | Jun 30, 2019 | $1.92M | +128.8% |
| Q1 FY2019 | Mar 31, 2019 | $1.51M | +77.3% |
| Q4 FY2018 | Dec 31, 2018 | $1.29M | +63.8% |
| Q3 FY2018 | Sep 30, 2018 | $847.47K | +15.2% |
| Q2 FY2018 | Jun 30, 2018 | $837.69K | +18.9% |
| Q1 FY2018 | Mar 31, 2018 | $852.92K | +14.3% |
| Q4 FY2017 | Dec 31, 2017 | $789.74K | +23.8% |
| Q3 FY2017 | Sep 30, 2017 | $735.87K | +20.5% |
| Q2 FY2017 | Jun 30, 2017 | $704.73K | – |
| Q1 FY2017 | Mar 31, 2017 | $745.94K | – |
| Q4 FY2016 | Dec 31, 2016 | $638.02K | – |
| Q3 FY2016 | Sep 30, 2016 | $610.83K | – |
See a number that looks wrong?